What Fueled The Previous Growth In The Hemoglobin A1c (HbA1c) Testing Market?
The hemoglobin a1c (hba1c) testing market has seen considerable growth due to a variety of factors.
• The hemoglobin A1c (HbA1c) testing market has grown rapidly in recent years. It will rise from $1.83 billion in 2024 to $2.03 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%.
This growth is attributed to the rising prevalence of diabetes, growing awareness and screening initiatives, expanding government healthcare policies, the development of healthcare infrastructure, an aging population, improved diagnostic accuracy, and the increased use of point-of-care testing.
What Is The Expected Growth In The Hemoglobin A1c (HbA1c) Testing Market Size Evolve over the Forecast Period?
The hemoglobin a1c (hba1c) testing market is expected to maintain its strong growth trajectory in upcoming years.
• The hemoglobin A1c (HbA1c) testing market is expected to experience rapid growth, reaching $3.02 billion by 2029, at a CAGR of 10.5%.
Growth is attributed to the increasing prevalence of lifestyle diseases, an increased focus on preventive healthcare, the expansion of emerging markets, the rise of personalized medicine, regulatory support, growing telemedicine, and remote monitoring. Trends include technological advancements, digital health platform integration, non-invasive testing technologies, and growth in telehealth.
What Main Forces Are Fueling Expansion In The Hemoglobin A1c (HbA1c) Testing Market?
The growing prevalence of diabetes is expected to accelerate the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a condition where the body struggles to control blood sugar levels due to inadequate insulin production or resistance. The rising incidence of diabetes is linked to poor dietary habits, especially the consumption of processed foods and sugary drinks, along with sedentary lifestyles. Additionally, the aging population and family history contribute to the increase in diabetes cases. HbA1c testing is used to monitor long-term blood sugar levels. The Lancet predicts global diabetes cases will rise from 529 million in 2021 to 1.3 billion by 2050. This trend is expected to fuel the growth of the HbA1c testing market.
What Are The Primary Segments In The Global Hemoglobin A1c (HbA1c) Testing Market?
The hemoglobin a1c (HbA1c) testing market covered in this report is segmented –
1) By Type: Laboratory Based Testing, Point Of Care (PoC) Testing
2) By Product Type: Instruments, Reagents, Kits
3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography, Other Technologies
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings, Other End Users
Subsegments:
1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry
2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits, Home Use Hba1c Monitoring Devices, Wireless Hba1c Testing Solutions
Pre-Book The Hemoglobin A1c (HbA1c) Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Hemoglobin A1c (HbA1c) Testing Market?
Leading firms in the hemoglobin A1c (HbA1c) testing market are concentrating on advancements in diagnostic test technology, such as HbA1c home tests, to provide more accurate, convenient, and easily accessible options for early identification and management of diabetes. HbA1c home tests are at-home diagnostic kits enabling individuals to calculate their average blood glucose levels over the past 2-3 months, aiding in the monitoring and management of diabetes. For instance, Hurdle Health, a US-centric company committed to offering ground-breaking healthcare solutions, including diagnostic instruments for chronic disease management, unveiled the Hemoglobin A1c (HbA1c) Test in February 2023. This innovative at-home blood sampling test allows adults to screen and monitor diabetes, aligning with Chronomics' objective of increasing accessibility to diagnostic tests and boosting health outcomes via direct-to-consumer solutions.
Who Are the Key Players In The Hemoglobin A1c (HbA1c) Testing Market?
Major companies operating in the hemoglobin A1c (HbA1c) testing market are:
• Roche Holding AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers
• Tosoh Corporation
• Hitachi High-Technologies Corporation
• Beckman Coulter Inc
• Sysmex Corporation
• Bio Rad Laboratories Inc
• ARKRAY Inc
• Randox Laboratories Ltd
• Ortho Clinical Diagnostics
• Agappe Diagnostics Ltd
• SEKISUI Diagnostics LLC
• Helena Laboratories
• Transasia Bio Medicals Ltd
• EKF Diagnostics
• Trinity Biotech plc
• HemoCue AB
• CPC Diagnostics Pvt Ltd
• PTS Diagnostics
• Menarini Diagnostics srl
• Diazyme Laboratories Inc
• Osang HealthCare Co Ltd
• Eurolyser Diagnostica GmbH
• DiaSys Diagnostic Systems GmbH
What Is The Most Dominant Region In The Hemoglobin A1c (HbA1c) Testing Market?
North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
